SCHEMBL9763745

SCHEMBL9763745

Nc1ccc(C#CCOCCCCCCO)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 6/20 0.48
▸ MAPT P10636 3/20 0.35
▸ HTR2A P28223 3/20 0.34
▸ HTR2C P28335 3/20 0.34
▸ HTR2B P41595 3/20 0.34
▸ SIGMAR1 Q99720 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ DRD2 P14416 2/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ MMP2 P08253 1/20 0.32
▸ MMP12 P39900 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18894300 0.79 APP (0.56) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL9763675 0.77 HRH3 (0.41) MAPTHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL22964321 0.77 GRM5 (0.37) APPHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL10465458 0.76 HRH3 (0.43) MAPTHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL1310397 0.76 MAPT (0.54) APPMAPTHTR2CHTR2BALDH1A1
SCHEMBL9763303 0.76 NPC1 (0.46) APPALDH1A1KDM4EKCNH2NPC1
SCHEMBL1310116 0.74 APP (0.50) APPMAPTALDH1A1KDM4ECYP1A2
SCHEMBL15131843 0.72 APP (0.54) APPMAPTHTR2AHTR2CALDH1A1
SCHEMBL31087902 0.72 APP (0.54) APPMAPTHTR2AHTR2CALDH1A1
SCHEMBL9763307 0.70 MAOB (0.46) APPALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990505-A Treating asthma, bronchitis; adrenergic stimulants GLAXO GROUP LIMITED (GB) 1991-02-05 — — US disclosed
Send feedback